A Phase 2 Double-Blind Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects

D
Domenick Zero, DDS, MS

Primary Investigator

J
Jessica MacLean

Primary Investigator

Overview

The purpose of the study is to evaluate the microbiological activity and safety of C16G2 Gel in male and female dental subjects, 12-75 years of age.

Description

The purpose of the study is to evaluate the microbiological activity and safety of C16G2 Gel in male and female dental subjects, 12-75 years of age.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    healthy
  • Age: - 100 Years
  • Gender: All
Updated on 20 Nov 2022. Study ID: 1510347972

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center